Division of Sun Pharmaceutical Industries Ltd.
Latest From Ohm Laboratories
Ranbaxy Laboratories is discussing with at least two companies with U.S. FDA-approved factories to supply it with the active pharmaceutical ingredients it relies on for its generic of AstraZeneca's Nexium (esomeprazole) for treating heartburn.
Ranbaxy Laboratories reportedly has filed formulation details with U.S. FDA for valsartan, the API of Novartis’ hypertension drug Diovan based upon a partnership with another multinational drug maker.
Ranbaxy’s compliance woes keep coming with the latest news that its crucial API facility was cited as a follow-up to FDA inspections. The fate of several of its key drugs hangs in the balance.
Ranbaxy Laboratories resumed exports of its generic of Pfizer’s cholesterol drug Lipitor to the U.S. in the wake of a lift of the four-year ban imposed by U.S. FDA at two of its India production facilities.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Sun Pharmaceutical Industries Ltd.
- Senior Management
- Contact Info
Phone: (732) 297-3030
PO Box 7397
N. Brunswick, NJ 08902
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.